Statements (55)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:healthcare_organization
|
gptkbp:bfsLayer |
4
|
gptkbp:bfsParent |
gptkb:Thomas_Mars
|
gptkbp:affects |
gptkb:psychologist
sedation analgesia |
gptkbp:aroma |
gptkb:fair
|
gptkbp:color |
colorless
|
gptkbp:composed_of |
from acetylene
from chloromethane from sodium hypochlorite |
gptkbp:cultural_heritage |
flammable
|
gptkbp:discovered_by |
gptkb:Samuel_Guthrie
|
gptkbp:dissolved |
0.8 g/ L
|
gptkbp:excretion |
urine
|
gptkbp:first_introduced |
1847
|
gptkbp:historical_event |
anesthetic in childbirth
anesthetic in dental procedures anesthetic in major surgeries anesthetic in military medicine anesthetic in veterinary medicine |
https://www.w3.org/2000/01/rdf-schema#label |
Chloroform
|
gptkbp:ingredients |
CH Cl3
|
gptkbp:is_used_for |
gptkb:item
|
gptkbp:mass |
119.38 g/mol
|
gptkbp:melting_point |
-63.5 ° C
61.2 ° C |
gptkbp:metabolism |
liver
|
gptkbp:number |
1888
|
gptkbp:population |
1.489 g/cm³
|
gptkbp:previous_name |
trichloromethane
|
gptkbp:regulatory_compliance |
controlled substance in some countries
restricted use in medical applications |
gptkbp:replaced_by |
halothane
isoflurane sevoflurane |
gptkbp:research |
studied for environmental impact
studied for effects on the nervous system studied for metabolic pathways studied for potential alternatives studied for toxicity levels |
gptkbp:safety_features |
hepatotoxicity
carcinogenicity |
gptkbp:side_effect |
gptkb:drug
dizziness nausea respiratory depression |
gptkbp:storage |
cool, dry place
|
gptkbp:type_of |
67-66-3
|
gptkbp:used_in |
gptkb:hospital
organic synthesis chemical research extraction laboratory analysis |
gptkbp:water_management |
hazardous waste
|